Particularly in relation to Vraylar
10% growth forecast raised
Largely as expected
Estimates for the second quarter of 2023
Q2 report due on Friday
Exchange rates to have adverse affect this year
Pharma firm publishes first quarter results
Here's the fresh consensus
Here are the latest figures
High interest rate environment does wonders
Higher interest rates come in handy
Management is cautious
2022 results released
Several records were achieved last year, though
Q4 earnings report published
Revenue growth target also seen overshot
Q4 did not bring new highs, though
For the fourth quarter of 2022
Analysts do not project yet another record, though
Regional banks play the main role in a relatively easy-to-explain story